As we head full steam into the fourth quarter traditionally the strongest quarter for device sales, insulin pumps in particular news coming out of the Pacific Northwest isn’t promising. We recently reviewed the new reimbursement policy put out by Regence Blue Cross and Blue Shield one of the largest payors in the area. A policy that unfortunately will make getting an insulin pump, sensor augmented pumps in particular more difficult for the patient and their physician.
We aren’t surprised that Regence is doing this as for we all know reimbursement policies have nothing to do with what’s . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.